Cargando…

Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells

Previous studies have investigated the inhibitory effect of BMI-1026 on cyclin-dependent kinase 1 in vitro. However, the molecular mechanisms by which BMI-1026 treatment leads to cancer cell death remain unclear. This study was conducted to investigate the anticancer mechanisms of BMI-1026 on human...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong Eun, Lee, Jinho, Park, Jong Wook, Kang, Hyunsu, Nam, Yu Ri, Kwon, Taeg Kyu, Kim, Ki-Suk, Kim, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073842/
https://www.ncbi.nlm.nih.gov/pubmed/33924053
http://dx.doi.org/10.3390/ijms22084268
_version_ 1783684222775459840
author Kim, Dong Eun
Lee, Jinho
Park, Jong Wook
Kang, Hyunsu
Nam, Yu Ri
Kwon, Taeg Kyu
Kim, Ki-Suk
Kim, Shin
author_facet Kim, Dong Eun
Lee, Jinho
Park, Jong Wook
Kang, Hyunsu
Nam, Yu Ri
Kwon, Taeg Kyu
Kim, Ki-Suk
Kim, Shin
author_sort Kim, Dong Eun
collection PubMed
description Previous studies have investigated the inhibitory effect of BMI-1026 on cyclin-dependent kinase 1 in vitro. However, the molecular mechanisms by which BMI-1026 treatment leads to cancer cell death remain unclear. This study was conducted to investigate the anticancer mechanisms of BMI-1026 on human renal carcinoma Caki cells. BMI-1026 induced apoptosis in association with the cleavage of poly(ADP-ribose) polymerase and pro-caspase-3 and the release of apoptosis-inducing factor and cytochrome c from mitochondria in Caki cells. BMI-1026-induced apoptosis was inhibited by the pan-caspase inhibitor z-VAD-fmk. Furthermore, BMI-1026 downregulated Bcl-2 and X-linked inhibitor of apoptosis protein (XIAP) at the transcriptional level and Mcl-1 (L) and cellular FADD-like IL-1β-converting enzyme inhibitory protein (c-FLIP (L)) at the post-transcriptional level. Interestingly, Mcl-1 (L) and c-FLIP (L), but not Bcl-2 or XIAP, played important roles in BMI-1026-induced Caki cell apoptosis. Although the constitutively active form of Akt did not attenuate BMI-1026-induced apoptosis, blockade of the PI3K/Akt pathway using a subcytotoxic concentration of the PI3K/Akt inhibitor LY294002 enhanced Caki cell apoptosis induced by BMI-1026. Electrophysiological safety was confirmed by determining the cardiotoxicity of BMI-1026 via left ventricular pressure analysis. These results suggest that BMI-1026 is a potent multitarget anticancer agent with electrophysiological safety and should be further investigated.
format Online
Article
Text
id pubmed-8073842
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80738422021-04-27 Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells Kim, Dong Eun Lee, Jinho Park, Jong Wook Kang, Hyunsu Nam, Yu Ri Kwon, Taeg Kyu Kim, Ki-Suk Kim, Shin Int J Mol Sci Article Previous studies have investigated the inhibitory effect of BMI-1026 on cyclin-dependent kinase 1 in vitro. However, the molecular mechanisms by which BMI-1026 treatment leads to cancer cell death remain unclear. This study was conducted to investigate the anticancer mechanisms of BMI-1026 on human renal carcinoma Caki cells. BMI-1026 induced apoptosis in association with the cleavage of poly(ADP-ribose) polymerase and pro-caspase-3 and the release of apoptosis-inducing factor and cytochrome c from mitochondria in Caki cells. BMI-1026-induced apoptosis was inhibited by the pan-caspase inhibitor z-VAD-fmk. Furthermore, BMI-1026 downregulated Bcl-2 and X-linked inhibitor of apoptosis protein (XIAP) at the transcriptional level and Mcl-1 (L) and cellular FADD-like IL-1β-converting enzyme inhibitory protein (c-FLIP (L)) at the post-transcriptional level. Interestingly, Mcl-1 (L) and c-FLIP (L), but not Bcl-2 or XIAP, played important roles in BMI-1026-induced Caki cell apoptosis. Although the constitutively active form of Akt did not attenuate BMI-1026-induced apoptosis, blockade of the PI3K/Akt pathway using a subcytotoxic concentration of the PI3K/Akt inhibitor LY294002 enhanced Caki cell apoptosis induced by BMI-1026. Electrophysiological safety was confirmed by determining the cardiotoxicity of BMI-1026 via left ventricular pressure analysis. These results suggest that BMI-1026 is a potent multitarget anticancer agent with electrophysiological safety and should be further investigated. MDPI 2021-04-20 /pmc/articles/PMC8073842/ /pubmed/33924053 http://dx.doi.org/10.3390/ijms22084268 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Dong Eun
Lee, Jinho
Park, Jong Wook
Kang, Hyunsu
Nam, Yu Ri
Kwon, Taeg Kyu
Kim, Ki-Suk
Kim, Shin
Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells
title Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells
title_full Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells
title_fullStr Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells
title_full_unstemmed Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells
title_short Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells
title_sort cyclin-dependent kinase inhibitor bmi-1026 induces apoptosis by downregulating mcl-1 (l) and c-flip (l) and inactivating p-akt in human renal carcinoma cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073842/
https://www.ncbi.nlm.nih.gov/pubmed/33924053
http://dx.doi.org/10.3390/ijms22084268
work_keys_str_mv AT kimdongeun cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells
AT leejinho cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells
AT parkjongwook cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells
AT kanghyunsu cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells
AT namyuri cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells
AT kwontaegkyu cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells
AT kimkisuk cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells
AT kimshin cyclindependentkinaseinhibitorbmi1026inducesapoptosisbydownregulatingmcl1landcfliplandinactivatingpaktinhumanrenalcarcinomacells